SALT LAKE CITY, Nov. 5, 2012 /PRNewswire/ -- Amedica Corporation, a spinal and reconstructive medical device manufacturer, announced today that esteemed financial executive Jay M. Moyes has been elected to its Board of Directors.
Mr. Moyes brings more than 30 years of management and leadership experience to the Amedica Board of Directors. He has been instrumental in the financial development and expansion of some of the medical industry's most groundbreaking companies including Myriad Genetics, where he guided the company through its initial public offering. Mr. Moyes currently sits on the Board of Directors with multiple biotechnology companies including Osiris Therapeutics Inc., Biocardia Inc., Integrated Diagnostics Inc., and Puma Biotechnology Inc. He formerly held a Board position with the Utah Life Science Industry Association.
"Jay brings a unique perspective to the Amedica leadership team. His experience and insight are incredibly valued as we work to further establish Amedica's position in the orthopedic industry," said Eric K. Olson, President and Chief Executive Officer, Amedica. "We look forward to drawing on the depth of his knowledge and business expertise as we expand our market penetration and continue developing innovative products that provide both clinical and economic value."
Throughout Mr. Moyes's career, he has worked with numerous industry-leading companies through their transformation from emerging growth to established, publicly-traded companies. Most recently, he served as Chief Financial Officer at XDX, an emerging molecular diagnostics company. Previously he served in the same role at Myriad Genetics, a publicly traded, leading biotechnology company focused on molecular diagnostics and therapeutic development. Prior to Myriad, Mr. Moyes served as Chief Financial Officer of Genmark, an agricultural biotechnology company, and as a Senior Manager with the international public accounting firm of KPMG. He holds a Masters in Business Administration from the University of Utah and received his undergraduate degree in economics from Weber State University.
About AMEDICA Corporation:
Amedica is an innovative spine and orthopaedic implant and device manufacturing and distribution company that provides advanced surgical applications including silicon nitride ceramic technologies. The company's platform technologies represent a new standard for implants and biologics based on superior performance, safety and efficacy. Amedica is a privately held, private equity backed company founded in 1996 by internationally recognized orthopaedic surgeons and ceramicists. The company is ISO 13485 certified, its spine products are FDA cleared, CE marked, and sold in ten countries. Amedica Corporation is based in Salt Lake City, UT.
Stacey Holifield / Heather McIntyre
SOURCE Amedica Corporation